| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/08/2007 | EP1814881A2 Carboxylic acid peri - substituted bicyclics for occlusive artery disease |
| 08/08/2007 | EP1678180B1 Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 08/08/2007 | EP1625116B1 Process for the preparation of carbostyril derivatives,such as aripiprazole and its intermediates |
| 08/08/2007 | EP1349962A4 Methods and compositions for detecting polynucleotide duplex damage |
| 08/08/2007 | EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330655C Phthalocyanine compounds, ink compositions comprising said compounds, and printing process therewith |
| 08/08/2007 | CN1330654C Fused bicyclic pyrimidine derivatives |
| 08/08/2007 | CN1330647C Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 08/08/2007 | CN1330309C Preventives or remedies for diseases caused by e NOS expression |
| 08/08/2007 | CN101014604A 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same |
| 08/08/2007 | CN101014603A Compounds and methods for inhibiting mitotic progression by ingibiting aurora kinase |
| 08/08/2007 | CN101014598A Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/08/2007 | CN101014589A Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 08/08/2007 | CN101014578A 三唑衍生物或其盐 Triazole derivative or salt thereof |
| 08/08/2007 | CN101014346A Anti-parasitic and/or anti-viral and/or anti-microbial compositions |
| 08/07/2007 | US7253290 3-[2,2-dimethyl-3-oxo-3-(7-azabicyclo[2.2.1]heptan-7-yl)propoxy]-4-[(1S)-1-methyl-2-[(isopropoxycarbonyl)imino(-3-pyridin-4-yl-pyrrolidin-1-yl)methyl]aminoethyl]-5-(3,5-dimethylphenyl)-1H-pyrazole; prodrugs for treating prostatic cancer, uterine cancer, breast cancer and pituitary gonadotrophe adenoma |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea |
| 08/07/2007 | US7253207 Quinones as disease therapies |
| 08/07/2007 | US7253203 Indoline derivatives |
| 08/07/2007 | US7253180 Viricides; immunology moderator |
| 08/07/2007 | US7253177 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
| 08/07/2007 | US7253169 Aza compounds, pharmaceutical compositions and methods of use |
| 08/07/2007 | US7253168 Substituted 1-benzyl-4-substituted piperazine analogues |
| 08/07/2007 | US7253167 Tricyclic-heteroaryl compounds useful as kinase inhibitors |
| 08/07/2007 | US7253166 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells |
| 08/07/2007 | US7253154 Substituted thiazolopyrimidines as xanthine oxidase inhibitors |
| 08/07/2007 | CA2332007C Adenosine a3 receptor modulators |
| 08/07/2007 | CA2192360C Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme |
| 08/02/2007 | WO2007087395A2 UNSATURATED mTOR INHIBITORS |
| 08/02/2007 | WO2007087283A2 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 08/02/2007 | WO2007087276A1 Aurora kinase modulators and method of use |
| 08/02/2007 | WO2007087250A2 Tricyclic inhibitors of 5-lipoxygenase |
| 08/02/2007 | WO2007086537A1 Method of manufacturing phthalocyanine compound |
| 08/02/2007 | WO2007085930A1 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 08/02/2007 | WO2007085873A1 Treatment of alzheimer's disease and related conditions |
| 08/02/2007 | WO2007076127A3 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators |
| 08/02/2007 | WO2007017602A3 Marqueurs, leur procede de fabrication et leurs applications |
| 08/02/2007 | WO2007017469A3 Process for preparing an angiotensin ii receptor antagonist |
| 08/02/2007 | WO2005065150A3 Mutagenic heterocycles |
| 08/02/2007 | US20070179297 Chemical compounds |
| 08/02/2007 | US20070179295 Triazolopyrimidines |
| 08/02/2007 | US20070179285 Method for producing alkoxy-substituted phthalocyanins |
| 08/02/2007 | US20070179177 Azaindazoles useful as inhibitors of kinases |
| 08/02/2007 | US20070179171 Vinca derivatives |
| 08/02/2007 | US20070179170 Vinorelbine derivatives |
| 08/02/2007 | US20070179165 Cyclic compounds |
| 08/02/2007 | US20070179163 Process for the preparation of risperidone |
| 08/02/2007 | US20070179162 Triazolopyrimdines |
| 08/02/2007 | US20070179161 Pyrazolopyrimidine compounds and their use in medicine |
| 08/02/2007 | US20070179160 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179137 Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives |
| 08/02/2007 | US20070179130 c-MET MODULATORS AND METHOD OF USE |
| 08/02/2007 | US20070179124 Substituted Porphyrins |
| 08/02/2007 | US20070179061 Aminotriazolopyrimidines, their preparation and their use for controlling harmful fungi, and compositions comprising these compounds |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | CA2640386A1 Treatment of alzheimer's disease and related conditions |
| 08/02/2007 | CA2637335A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 08/02/2007 | CA2635211A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 08/01/2007 | EP1813615A1 Optical filter and its applications, and porphyrin compound used in optical filter |
| 08/01/2007 | EP1813614A1 Cytotoxic agents comprising new tomaymycin derivatives |
| 08/01/2007 | EP1813613A1 Novel fused imidazole derivative |
| 08/01/2007 | EP1812442A2 Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 08/01/2007 | EP1812441A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
| 08/01/2007 | EP1812440A1 PYRAZOLOÝ1,5-a¨PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES |
| 08/01/2007 | EP1812439A2 Kinase inhibitors |
| 08/01/2007 | EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 08/01/2007 | EP1812007A2 Pyridazine compounds and methods |
| 08/01/2007 | EP1812004A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1812003A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1811994A1 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy |
| 08/01/2007 | EP1725557B1 6-(2-chloro-5-halophenyl)-triazolopyrimidine, method for production and use thereof for controlling fungal pests and agents comprising the same |
| 08/01/2007 | EP1581528B1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
| 08/01/2007 | EP1476446B1 Method for producing n-ethyl-n-( 3-(3-cyanopyrazolo-(1,5a)-pyrimidine-7-yl)phenyl)-acetamide |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 08/01/2007 | EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents |
| 08/01/2007 | EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/01/2007 | EP1005470B1 Oxindolylquinazoline derivatives as angiogenesis inhibitors |
| 08/01/2007 | CN1329394C Novel imidazole derivatives, production method thereof and use thereof |
| 08/01/2007 | CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 08/01/2007 | CN1329034C Method for preventing/treating damage to sensory hair cells and cochlear neurons |
| 08/01/2007 | CN101010324A Method for preparing pyrrolotriazine compounds |
| 08/01/2007 | CN101010106A Conjugates of antibody and Duocarmycin derivatives as antitumor agents |
| 08/01/2007 | CN101007814A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof |
| 08/01/2007 | CN101007781A Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom |
| 07/31/2007 | US7250443 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 07/31/2007 | US7250424 Fab I inhibitors |
| 07/31/2007 | US7250420 Using a pyrrolo(2,3-d)pyrimidine compound |
| 07/31/2007 | US7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 07/31/2007 | US7250417 Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors |
| 07/31/2007 | CA2184802C Process for manufacture of imidazo benzodiazepine derivatives |
| 07/26/2007 | WO2007084882A2 Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein |
| 07/26/2007 | WO2007084394A2 2,5 diaza-bicyclo[2.2.1]heptane derivatives as calcium channel blockers |
| 07/26/2007 | WO2007084073A1 Novel compounds and use thereof |
| 07/26/2007 | WO2007083978A1 Imidazopyridine derivatives inhibiting protein kinase activity, method for the preparation thereof and pharmaceutical composition containing same |
| 07/26/2007 | WO2007083188A2 Improved process for the preparation of an optically active 5h-pyrrolo [3,4-b] pyrazine derivative |
| 07/26/2007 | WO2007082946A1 Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents |